New York State Common Retirement Fund’s Stoke Therapeutics STOK Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $121K | Hold |
10,635
| – | – | ﹤0.01% | 2475 |
|
2025
Q1 | $71K | Hold |
10,635
| – | – | ﹤0.01% | 2658 |
|
2024
Q4 | $117K | Hold |
10,635
| – | – | ﹤0.01% | 2534 |
|
2024
Q3 | $131K | Hold |
10,635
| – | – | ﹤0.01% | 2480 |
|
2024
Q2 | $144K | Buy |
10,635
+52
| +0.5% | +$704 | ﹤0.01% | 2574 |
|
2024
Q1 | $143K | Sell |
10,583
-59
| -0.6% | -$797 | ﹤0.01% | 2598 |
|
2023
Q4 | $56K | Sell |
10,642
-46
| -0.4% | -$242 | ﹤0.01% | 2962 |
|
2023
Q3 | $42K | Buy |
10,688
+122
| +1% | +$479 | ﹤0.01% | 3073 |
|
2023
Q2 | $112K | Sell |
10,566
-3,832
| -27% | -$40.6K | ﹤0.01% | 2744 |
|
2023
Q1 | $120K | Hold |
14,398
| – | – | ﹤0.01% | 2765 |
|
2022
Q4 | $133K | Buy |
14,398
+3
| +0% | +$28 | ﹤0.01% | 2878 |
|
2022
Q3 | $185K | Buy |
14,395
+66
| +0.5% | +$848 | ﹤0.01% | 2799 |
|
2022
Q2 | $189K | Sell |
14,329
-46
| -0.3% | -$607 | ﹤0.01% | 2817 |
|
2022
Q1 | $303K | Buy |
14,375
+17
| +0.1% | +$358 | ﹤0.01% | 2646 |
|
2021
Q4 | $344K | Sell |
14,358
-2,243
| -14% | -$53.7K | ﹤0.01% | 2640 |
|
2021
Q3 | $422K | Buy |
16,601
+94
| +0.6% | +$2.39K | ﹤0.01% | 2558 |
|
2021
Q2 | $556K | Buy |
16,507
+3,307
| +25% | +$111K | ﹤0.01% | 2539 |
|
2021
Q1 | $513K | Buy |
13,200
+2,100
| +19% | +$81.6K | ﹤0.01% | 2444 |
|
2020
Q4 | $687K | Hold |
11,100
| – | – | ﹤0.01% | 2194 |
|
2020
Q3 | $372K | Hold |
11,100
| – | – | ﹤0.01% | 2356 |
|
2020
Q2 | $265K | Buy |
11,100
+1,500
| +16% | +$35.8K | ﹤0.01% | 2528 |
|
2020
Q1 | $220K | Hold |
9,600
| – | – | ﹤0.01% | 2419 |
|
2019
Q4 | $272K | Hold |
9,600
| – | – | ﹤0.01% | 2585 |
|
2019
Q3 | $206K | Buy |
+9,600
| New | +$206K | ﹤0.01% | 2756 |
|